Do enjoy -- this will be one of five or seven in a series, depending on how ambitious I feel this week. [And whether the Qatari "trojan horse" deal gets done. Hah.]
. . .H.R. 1244, Reducing Drug Prices for Seniors Act; H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025; S. 1040, Drug Competition Enhancement Act; S. 1339, Pharmacy Benefit Manager Reform Act; S. 2076 Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act of 2021. . . .
Issues relating to [US House]: 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Prescription drug cost-sharing; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines issues; Vaccine misinformation; Measles, Mumps, and Rubella (MMR) immunizations; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical supply channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; FY-2025 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO IP Waiver for COVID therapeutics; Animal Health; Animal Health Technology Issues; Animal Health Policy Issues: Animal Drug User Fee Act (ADUFA) & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues. . . .
H.R. 1244, Reducing Drug Prices for Seniors Act; Issues relating to [Senate]: Medicare; Medicare Part B and D drug pricing issues; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; FY-2025 Budget and Appropriations Legislation; Medicaid drug rebate program (MDRP). . . .Issues relating to [House & Senate]: Tax reform and tax policy, generally; Tax Cuts and Jobs Act of 2017 (P.L. 115-97); Inflation Reduction Act (P.L. 117-169), provisions relating to budget reconciliation and taxes. . . .
H.R. 8467, Farm, Food, and National Security Act of 2024; Issues relating to: United Stated Department of Agriculture; Animal and Plant Health Inspection Service; Final Rule regarding use of electronic identification eartags as official identification in cattle and bison (89 Fed. Reg. 39,541 -- 39,566, May 9, 2024). . . .
Now you know. But this will now prove out. . . that Tangerine's silly Sharpie is no match for world class lobbying efforts. They've already (long ago) won the match -- in the House and Senate. Out.
नमस्ते